These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9820938)

  • 21. Morphological and fluorophotometric analysis of the corneal endothelium after radial keratotomy.
    Tseng SH; Chen FK
    Cornea; 1998 Sep; 17(5):471-5. PubMed ID: 9756440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
    Nordmann JP; Mertz B; Yannoulis NC; Schwenninger C; Kapik B; Shams N;
    Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Latrunculins' effects on intraocular pressure, aqueous humor flow, and corneal endothelium.
    Peterson JA; Tian B; McLaren JW; Hubbard WC; Geiger B; Kaufman PL
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1749-58. PubMed ID: 10845595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost.
    Miura K; Ito K; Okawa C; Sugimoto K; Matsunaga K; Uji Y
    J Glaucoma; 2008; 17(3):233-7. PubMed ID: 18414111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical timolol with and without benzalkonium chloride: epithelial permeability and autofluorescence of the cornea in glaucoma.
    de Jong C; Stolwijk T; Kuppens E; de Keizer R; van Best J
    Graefes Arch Clin Exp Ophthalmol; 1994 Apr; 232(4):221-4. PubMed ID: 8034210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects on the intraocular pressure and visual field resulting from a switch in the treatment from timolol to betaxolol.
    Miki H; Miki K
    J Ocul Pharmacol Ther; 2004 Dec; 20(6):509-17. PubMed ID: 15684810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of timolol maleate on untreated contralateral eyes (author's transl)].
    Spinelli D; Montanari P; Vigasio F; Cormanni V
    J Fr Ophtalmol; 1982; 5(3):153-8. PubMed ID: 7096893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
    Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
    Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of latanoprost monotherapy and combined therapy of 0.5% timolol and 1% dorzolamide in chronic primary angle-closure glaucoma (CACG) in Japanese patients.
    Sakai H; Shinjyo S; Nakamura Y; Nakamura Y; Ishikawa S; Sawaguchi S
    J Ocul Pharmacol Ther; 2005 Dec; 21(6):483-9. PubMed ID: 16386090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
    Sonty S; Mundorf TK; Stewart JA; Stewart WC
    Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Timolol maleate in treatment of open angle glaucoma.
    Aasved H; Seland JH; Slagsvold JE
    Acta Ophthalmol (Copenh); 1979 Aug; 57(4):700-8. PubMed ID: 525294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the early effects of brimonidine and apraclonidine as topical ocular hypotensive agents.
    Maus TL; Nau C; Brubaker RF
    Arch Ophthalmol; 1999 May; 117(5):586-91. PubMed ID: 10326954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients.
    Krupin T; Liebmann JM; Greenfield DS; Rosenberg LF; Ritch R; Yang JW;
    Ophthalmology; 2005 Mar; 112(3):376-85. PubMed ID: 15745762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long term safety and tolerability of Tafluprost 0.0015% vs Timolol 0.1% preservative-free in ocular hypertensive and in primary open-angle glaucoma patients: a cross sectional study.
    Rolle T; Spinetta R; Nuzzi R
    BMC Ophthalmol; 2017 Aug; 17(1):136. PubMed ID: 28768500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Timolol: a review of its therapeutic efficacy in the topical treatment of glaucoma.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1979 Jan; 17(1):38-55. PubMed ID: 369807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Latanoprostene Bunod 0.024% Compared With Timolol 0.5% in Lowering Intraocular Pressure Over 24 Hours.
    Liu JHK; Slight JR; Vittitow JL; Scassellati Sforzolini B; Weinreb RN
    Am J Ophthalmol; 2016 Sep; 169():249-257. PubMed ID: 27457257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vitro evaluation for corneal damages by anti-glaucoma combination eye drops using human corneal epithelial cell (HCE-T)].
    Nagai N; Murao T; Oe K; Ito Y; Okamoto N; Shimomura Y
    Yakugaku Zasshi; 2011; 131(6):985-91. PubMed ID: 21628988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compliance with timolol treatment in glaucoma.
    Rotchford AP; Murphy KM
    Eye (Lond); 1998; 12 ( Pt 2)():234-6. PubMed ID: 9683946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study.
    Katz LJ; Rauchman SH; Cottingham AJ; Simmons ST; Williams JM; Schiffman RM; Hollander DA
    Curr Med Res Opin; 2012 May; 28(5):781-8. PubMed ID: 22458918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The APOLLO Study.
    Weinreb RN; Scassellati Sforzolini B; Vittitow J; Liebmann J
    Ophthalmology; 2016 May; 123(5):965-73. PubMed ID: 26875002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.